Influence of von Willebrand factor on the reactivity of human factor VIII inhibitors with factor VIII
- 12 July 2001
- journal article
- Published by Wiley in Haemophilia
- Vol. 7 (4) , 369-374
- https://doi.org/10.1111/j.1365-2516.2001.00526.x
Abstract
In order to determine the difference in reactivity of factor (F) VIII inhibitors against the FVIII/von Willebrand factor (vWF) complex and against vWF‐deficient FVIII, we investigated a panel of 10 antibodies to FVIII from multitransfused individuals with severe haemophilia A and other pathologies. Immunoblotting of purified FVIII and purified thrombin‐cleaved FVIII revealed that in all cases inhibitor epitopes could be localized in the heavy chain (A2 subunit) while in four cases they were also present in the light chain. One of the FVIII inhibitors remained unclassified. The effect on FVIII:C of purified IgG from inhibitor plasmas was tested against a high purity FVIII/vWF concentrate and a monoclonally purified FVIII concentrate with only trace contents of vWF, by two different functional assays. Our results suggest that for those inhibitors showing A2 plus light chain (LC) reactivity, the IgG concentration required to inhibit 50% of FVIII activityin vitrois higher for the FVIII/vWF complex than for the vWF‐deficient FVIII. We conclude that there might be a protective role of vWF (at leastin vitro) against FVIII inhibitors with A2 and LC subunit specificity.Keywords
This publication has 20 references indexed in Scilit:
- Variation in inhibitor reactivity in acquired haemophilia A with different concentratesClinical and Laboratory Haematology, 2000
- Role of Factor VIII C2 Domain in Factor VIII Binding to Factor XaJournal of Biological Chemistry, 1999
- Factor VIII Inhibitor Antibodies with C2 Domain Specificity Are Less inhibitory to Factor VIII Complexed with von Willebrand FactorThrombosis and Haemostasis, 1996
- Slowed Release of Thrombin-cleaved Factor VIII from von Willebrand Factor by a Monoclonal and a Human Antibody Is a Novel Mechanism for Factor VIII InhibitionPublished by Elsevier ,1996
- Variation in factor VIII inhibitor reactivity with different commercial factor VIII preparationsHaemophilia, 1996
- Human Anti-Factor VIII Antibodies: Epitope Localization and Inhibitory FunctionVox Sanguinis, 1996
- Autoantibody to factor VIII that has less reactivity to factor Vlll/von Willebrand Factor ComplexAmerican Journal of Hematology, 1995
- Localization of human factor FVIII inhibitor epitopes to two polypeptide fragments.Proceedings of the National Academy of Sciences, 1985
- Assay of Factor VIII:C with a Chromogenic SubstrateScandinavian Journal of Haematology, 1984
- Structure of human factor VIIINature, 1984